Simplex Trading, LLC Gemini Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$1.31 - $2.01 $15,735 - $24,144	12,012 Added 2407.21%	12,511 $20,000
Q2 2022 Aug 03, 2022	BUY	$1.22 - $1.73 $608 - $863	499 New	499 $0
Q1 2022 May 02, 2022	SELL	$1.29 - $3.08 $19,893 - $47,496	-15,421 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.39 - $4.0 $34,325 - $57,448	14,362 Added 1356.19%	15,421 $44,000
Q2 2021 Aug 12, 2021	SELL	$6.32 - $14.02 $310,609 - $689,040	-49,147 Reduced 97.89%	1,059 $6,000
Q1 2021 Apr 26, 2021	BUY	$11.32 - $18.0 $568,331 - $903,708	50,206 New	50,206 $680,000

2.44M

Ticker GMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,244,500
Market Cap $1.05B
Description
Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.